Department of Neurosurgery and China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University, Beijing, China.
Center of Cerebrovascular Disease Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
CNS Neurol Disord Drug Targets. 2013 May 1;12(3):413-425. doi: 10.2174/1871527311312030014.
Traumatic brain injury (TBI) is a leading cause of cell death and disability among young adults and lacks a successful therapeutic strategy. The multiphasic injuries of TBI severely limit the success of conventional pharmacological approaches. Recent successes with transplantation of stem cells in bioactive scaffolds in other injury paradigms provide new hope for the treatment of TBI. In this study, we transplanted neural stem cells (0.5x10(5) cells/µl) cultured in a bioactive scaffold derived from porcine urinary bladder matrix (UBM; 4 injection sites, 2.5µl each) into the rat brain following controlled cortical impact (CCI, velocity, 4.0 m/sec; duration, 0.5 sec; depth, 3.2mm). We evaluated the effectiveness of this strategy to combat the loss of motor, memory and cognitive faculties. Before transplantation, compatibility experiments showed that UBM was able to support extended proliferation and differentiation of neural stem cells. Together with its reported anti-inflammatory properties and rapid degradation characteristics in vivo, UBM emerged to be an ideal scaffold. The transplants reduced neuron/tissue loss and white matter injury, and also significantly ameliorated motor, memory, and cognitive impairments. Furthermore, exposure to UBM alone was sufficient to decrease the loss of sensorimotor skills from TBI (examined 3-28 days post-CCI). However, only UBMs that contained proliferating neural stem cells helped attenuate memory and cognitive impairments (examined 26-28 days post-CCI). In summary, these results demonstrate the therapeutic efficacy of stem cells in bioactive scaffolds against TBI and show promise for translation into future clinical use.
创伤性脑损伤(TBI)是导致年轻人细胞死亡和残疾的主要原因,目前缺乏有效的治疗策略。TBI 的多相损伤严重限制了传统药物治疗方法的成功。最近,在其他损伤模型中,将干细胞移植到具有生物活性的支架中的成功为 TBI 的治疗提供了新的希望。在这项研究中,我们将培养在源自猪尿路上皮基质(UBM)的生物活性支架中的神经干细胞(0.5x10(5)细胞/µl;4 个注射部位,每个部位 2.5µl)移植到大鼠大脑中,随后进行皮质控制冲击(CCI,速度为 4.0m/sec;持续时间为 0.5 秒;深度为 3.2mm)。我们评估了这种策略在对抗运动、记忆和认知能力丧失方面的有效性。在移植之前,相容性实验表明 UBM 能够支持神经干细胞的扩展增殖和分化。再加上其报道的抗炎特性和体内快速降解特性,UBM 成为了一种理想的支架。移植减少了神经元/组织损失和白质损伤,并且显著改善了运动、记忆和认知障碍。此外,单独暴露于 UBM 就足以减轻 TBI 造成的感觉运动技能丧失(在 CCI 后 3-28 天检查)。然而,只有包含增殖神经干细胞的 UBM 才能帮助减轻记忆和认知障碍(在 CCI 后 26-28 天检查)。总之,这些结果表明生物活性支架中的干细胞对 TBI 具有治疗效果,并为未来的临床应用转化提供了希望。